- Home
- UPXI vs CELZ Comparison
UPXI vs CELZ Comparison
Compare UPXI & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPXI
- CELZ
- Stock Information
- Founded
- UPXI 2018
- CELZ 1998
- Country
- UPXI United States
- CELZ United States
- Employees
- UPXI N/A
- CELZ N/A
- Industry
- UPXI Medicinal Chemicals and Botanical Products
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- UPXI Health Care
- CELZ Health Care
- Exchange
- UPXI Nasdaq
- CELZ Nasdaq
- Market Cap
- UPXI 4.6M
- CELZ 5.5M
- IPO Year
- UPXI 2021
- CELZ N/A
- Fundamental
- Price
- UPXI $2.16
- CELZ $2.24
- Analyst Decision
- UPXI
- CELZ
- Analyst Count
- UPXI 0
- CELZ 0
- Target Price
- UPXI N/A
- CELZ N/A
- AVG Volume (30 Days)
- UPXI 12.7K
- CELZ 127.1K
- Earning Date
- UPXI 05-07-2025
- CELZ 05-09-2025
- Dividend Yield
- UPXI N/A
- CELZ N/A
- EPS Growth
- UPXI N/A
- CELZ N/A
- EPS
- UPXI N/A
- CELZ N/A
- Revenue
- UPXI $18,625,089.00
- CELZ $11,000.00
- Revenue This Year
- UPXI $299.03
- CELZ N/A
- Revenue Next Year
- UPXI N/A
- CELZ N/A
- P/E Ratio
- UPXI N/A
- CELZ N/A
- Revenue Growth
- UPXI 4.75
- CELZ 22.22
- 52 Week Low
- UPXI $2.03
- CELZ $1.92
- 52 Week High
- UPXI $15.91
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- UPXI 37.17
- CELZ 36.34
- Support Level
- UPXI $2.03
- CELZ $1.95
- Resistance Level
- UPXI $2.25
- CELZ $2.50
- Average True Range (ATR)
- UPXI 0.14
- CELZ 0.34
- MACD
- UPXI 0.02
- CELZ -0.06
- Stochastic Oscillator
- UPXI 23.01
- CELZ 22.54
About UPXI Upexi Inc.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products. It reaches consumers through its direct-to-consumer network, wholesale partnerships, and prominent third-party platforms like Amazon.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.